Back to Journals » Drug Design, Development and Therapy » Volume 11

Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials

Total article views   Abstract views HTML views PDF downloads Totals
5,940 Dovepress* 4,461 427+ 542 4,888
PubMed Central* 0 1,052 237 1,052
Totals 4,461 1,479 779 5,940
*Since 13 October 2017
+Since July 2016

View citations on PubMed Central and Google Scholar